Stocktoria

Anteris Technologies Global Corp. AVR

Nasdaq · XNAS · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2024-12-13
Chart by TradingView
2/9
Piotroski F — financial health
Altman Z″ — distress risk
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024
Financials
Revenue$1.9M$2.7M
Operating income-$93.9M-$78.4M
Net income-$94.1M-$76.3M
Operating cash flow-$77.8M-$61.2M
Free cash flow-$79.8M-$63.5M
Total assets$23.0M$80.7M
Total liabilities$23.2M$18.0M
Shareholders' equity-$93,000$62.7M
Ratios
Operating margin-4908.2%-2899.4%
Net margin-4921.3%-2822.5%
FCF margin-4169.2%-2349.5%
Return on assets-409.4%-94.5%
Return on equity101230.1%-121.7%
Current ratio0.734.51
Revenue growth-29.2%

Why these scores methodology →

Piotroski F-score: 2/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: n/a

Not applicable (financials/insurer or missing inputs).

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0002011514 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.